by Andreu Prados
In a recent study, led by Dr. Matteo Serino from the Institut Nacional de la Santé et de la Recherche Médicale (INASERM) in Toulouse (France), has found that transfer of a dysbiotic microbiota had the capacity to induce metabolic effects that appear beneficial.
by Andreu Prados
A recent randomized has found that prebiotic supplementation may influence appetite control and energy intake in children with overweight and obesity.
by Andreu Prados
A recent cross-sectional study, led by Prof. Tim Spector and Dr. Jordana Bell from the Department of Twin Research & Genetic Epidemiology at King’s College London (United Kingdom), has found that the human faecal microbiome is related to abdominal adiposity.
by Kristina Campbell
Individuals may experience recurrent weight gain and re-emergence of metabolic complications, a phenomenon sometimes called the "yo-yo effect". But growing evidence of the role of gut microbiota in obesity and metabolic health may bring the potential to address this problem in new ways.
by Andreu Prados
The MoBioFood (Molecular Bioactivity of Foods) Research Group from the Biochemistry and Biotechnology Department at the Rovira i Virgili University in Tarragona (Spain) focuses on the interaction of flavonoids with the enteroendocrine system, and the role of these compounds in maintaining intestinal barrier integrity and/or inducing anti-inflammatory effects in the gastrointestinal tract.
by Kristina Campbell
Previous studies have identified Akkermansia muciniphila as an important bacterium in metabolic health—able to prevent the development of obesity in animal models. Until now, however, its mechanisms were unclear and its effects had never been tested in humans.
by Andreu Prados
Now a recent study, led by Dr. Nicola Santoro from the Department of Paediatrics at Yale University in New Haven, Connecticut (USA), has found that the gut microbiota of obese youth may drive a higher accumulation of energy than that of lean adolescents through an elevated production of short-chain fatty acids (SCFAs) and a higher capability to oxidize carbohydrates.
by Andreu Prados
A recent study, led by Dr. Martin J. Blaser from the Departments of Medicine and Microbiology at New York University Langone Medical Centre in New York (USA), has found that early-life antibiotic exposure in non-obese diabetic mice may accelerate T1D development.
by Andreu Prados
A recent randomized double-blind placebo-controlled trial, led by Dr. Ellen Blaak from the Department of Human Biology at Maastricht University Medical Centre in Maastricht (The Netherlands), has found that a 7-day antibiotic treatment does not affect host metabolism in obese humans in the short term, despite profound changes in gut microbial diversity and composition.
by Andreu Prados
A recent study, led by Dr. Wendy A. Henderson from the National Institute of Nursing Research at National Institutes of Health (NIH) in Bethesda (USA), and co-authored by Research Fellow Dr. Nicolaas Fourie, has found that the oral microbiota could be a useful source of information in patients with irritable bowel syndrome (IBS).
